Altace - MSN Newsfeeds
- HealthCentral.com - ACE inhibitors, such as ramipril (Altace), enalapril (Vasotec), and lisinopril (Zestril), lower blood pressure by blocking the production of a hormone known as angiotensin, which increases blood pressure. Angiotensin-2 (AT-2) receptor antagonists ...
- HealthCentral.com - Ramipril is a 2-aza-bicyclo [3.3.0]-octane-3-carboxylic acid derivative. It is a white, crystalline substance solu-ble in polar organic solvents and buffered aqueous solutions. Ramipril melts between 105° C and 112° C. The CAS Registry Number is ...
- Austin American-Statesman - Do I really want to attend a concert where instead of acid, everybody's dropping Altace? I can hear it now from the stage: "Don't take the brown Lamisil." Do I want to go to a concert where, instead of a mosh pit, people are exchanging ...
- PR Newswire - Recent news flow * In April Novartis confirmed that the U.S. Food and Drug Administration (FDA) have accepted ... SPP100 has potential in diabetic patients both as a monotherapy and in co-administration with the ACE inhibitor ramipril.
- Heart Info - ACE inhibitors, such as ramipril (Altace), enalapril (Vasotec), and lisinopril (Zestril), lower blood pressure by blocking ... The information provided on Heartinfo.org is for educational purposes only and does not serve as a replacement for care ...
- MSNBC - The top-sellers include Lotrel, Altace and Lisinopril. In the study, researchers studied Medicaid records on 29,507 Tennessee infants born between 1985 and 2000. Of those, 411 had mothers who took a blood pressure drug at least once during their first ...
- TriCities.com - Company executives told Wall Street analysts in a conference call Wednesday that Altace remains a key part of the company’s growth strategy. The announcement came amid news that King saw income of half a billion dollars in the second quarter, up ...
- Kingsport Times-News - Altace(R) net sales totaled $154 million during the second quarter of 2006, an increase of 7% from $144 million during the ... Kingsport Times-News - Subscribe | E-Edition | Vacation Notice | Support Sandusky Newspapers - Affiliate Sites and Other ...
- Phramalive.com - This growth was achieved due to the successful launches of 17 new products including Ramipril, Risperidone, Citalopram and ... Get Instant Access to our News Archive For more than 20 years, executives like you have relied on Engel ...
- TriCities.com - BRISTOL, Tenn. – King Pharmaceuticals has begun building a specialized, 88-person sales force to push its flagship product, hypertension pill Altace, as well as a new diabetes drug. Company executives told Wall Street analysts in a conference call ...
- Street.Com - Product price increases and lower administrative and marketing costs propelled King Pharmaceuticals ( KG - news - Cramer's Take ... King's bestselling drug, the blood pressure medication Altace, produced a 7%-gain in sales to $154 million. Sales of the ...
- Beurs.nl - Sales of Altace, the hypertension medication that's King's lead product, jumped 7% to $154 million for the quarter. Revenue from the company's medical technologies business leaped 52% to $54 million from the 2005 period. However, because of ...
- Genetic Engineering News - ... of 2006 included the successful restructuring of our Co-promotion Agreement covering our leading branded ACE inhibitor, Altace ... back to top © 2006 Genetic Engineering News, All Rights Reserved terms of use legal information privacy statement
- Forbes - There have been reports of low blood sugar in patients taking Altace(R) with medicine for diabetes. Patients should contact their doctor if they have symptoms of low blood sugar such as sweating or shakiness. Common side effects include persistent ...
- Health 24 - The good news – death rates from stroke and heart attack are on the decline. The bad news – the death rate from ... The drugs include captopril, enalapril and ramipril. ACE inhibitors help the failing heart by relaxing the arteries in the body.
- Onlypunjab.com - Health News Onlypunjab.com Research and Markets ( http://www.researchandmarkets.com/reports/c32022 ) has announced the ... for constituents of the metabolic syndrome (e.g., metformin, glibenclamide, simvastatin, lovastatin, pravastatin, ramipril ...
- Medscape News - A previous study found that ramipril was associated with a lower mortality after AMI compared with other ACE inhibitors. To ... 66 years or older who were admitted to the hospital for AMI and entered into a Canadian Institute of Health Information ...
- DVM Newsmagazine - A. Dr. Bonnie K. Lefbom at the 2005 American College of Veterinary Internal Medicine Forum in Baltimore gave a lecture on sildenafil and novel cardiovascular therapies. Some relevant points in this lecture and current information about ramipril are ...
- Medscape News - In a subsequent study in nephrotic patients, the Ramipril Efficacy In Nephropathy (REIN) core study, 3 months of proteinuria ... Remuzzi advises continuing ACE inhibitors while patients are on dialysis as those not on these drugs have a higher ...
- New Kerala - The company informed the Bombay Stock Exchange that the US District Court for the Eastern District of Virginia has issued an opinion following the completion of a trial on Sanofi-Aventis US Patent No - 5061722 relating to Altace (Ramipril) drug and ...
Pages: Previous 1 2 3 4 5 6 7 Next
These articles are related to: Altace Claim, Altace Lawsuit, Altace Law Suit, Altace Law Firm, Altace Lawyer, Altace Attorney, Altace Side Effects Symptoms, Altace Trial, Altace Verdict, Altace News, Altace Information, Altace Recall Lawyers, Altace Warning, Altace Class Action, Altace Prescription Drug, Altace Medication, Altace Drugs, Ramipril Claim, Ramipril Lawsuit, Ramipril Law Suit, Ramipril Law Firm, Ramipril Lawyer, Ramipril Attorney, Ramipril Side Effects Symptoms, Ramipril Trial, Ramipril Verdict, Ramipril News, Ramipril Information, Ramipril Recall Lawyers, Ramipril Warning, Ramipril Class Action, Ramipril Prescription Drug, Ramipril Medication, Ramipril Drugs



